November 19, 2021: Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.Continue reading
Category Archives: AZBio News
CooperCompanies to Acquire Generate Life Sciences® for $1.6 Billion
Acquisition will Expand CooperSurgical’s Fertility and Labor & Delivery OfferingsContinue reading
AdvaMed Cybersecurity Summit Previews the Future of Medical Device Cybersecurity
Experts from FDA and Industry will provide timely updates on the state of medical device cybersecurity, including issues related to FDA requirements and a preview of the future of medical device cybersecurity.Continue reading
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective StudiesContinue reading
Arizona Honors Cancer Caregivers
According to the American Cancer Society, in 2021, there will be an estimated 41,000 new cases of cancer in Arizona and an estimated 15,580 deaths will result from this disease. For for every new cancer patient diagnosed there will be at least one new cancer caregiver and/or family to care for that patient.Continue reading
AZBio and Verigility Host a Discussion on Building Resilient Teams as part of Global Entrepreneurship Week
The Arizona Bioindustry Association (AZBio) and Verigility hosted a discussion on Building Resilient Teams as part of Arizona’s Global Entrepreneurship Week celebration. Continue reading
C-Path Joins New Coalition to Improve Patient Care and Address Unmet Medical Needs through Community-Level Clinical Trials
Tools being developed by C-Path’s CURE Drug Repurposing Collaboratory will help incorporate adaptive platform trial protocols in clinical practice.Continue reading
C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease
TUCSON, Ariz., November 9, 2021 — Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint collaboration to significantly promote data sharing and accelerate Leigh syndrome and other rare mitochondrial disease data incorporation into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading
UArizona Alumnus R. Ken Coit Commits $50M to Advance College of Pharmacy
The transformative gift establishes endowed positions and scholarships and expands the college’s History of Pharmacy Museum. The college will be renamed in recognition of R. Ken Coit’s support.Continue reading
Mayo Clinic poised to biomanufacture a new era of biotherapeutics
Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions.